Header
Header
Article

Inflammation and nutritional status indicators as prognostic indicators for patients with locally advanced gastrointestinal stromal tumors treated with neoadjuvant imatinib | BMC Gastroenterology


  • Søreide K, Sandvik OM, Søreide JA, Giljaca V, Jureckova A, Bulusu VR. Global epidemiology of gastrointestinal stromal tumours (GIST): a systematic review of population-based cohort studies. Cancer Epidemiol. 2016;40:39–46.

    Article 

    Google Scholar
     

  • Arshad J, Ahmed J, Subhawong T, Trent JC. Progress in determining response to treatment in gastrointestinal stromal tumor. Expert Rev Anticancer Ther. 2020;20(4):279–88.

    Article 
    CAS 

    Google Scholar
     

  • Maki RG, Blay JY, Demetri GD, Fletcher JA, Joensuu H, Martín-Broto J, Nishida T, Reichardt P, Schöffski P, Trent JC. Key issues in the clinical management of gastrointestinal stromal tumors: an expert discussion. Oncologist. 2015;20(7):823–30. https://doi.org/10.1634/theoncologist.2014-0471.

    Article 

    Google Scholar
     

  • Nishida T, Yoshinaga S, Takahashi T, Naito Y. Recent progress and challenges in the diagnosis and treatment of gastrointestinal stromal tumors. Cancers. 2021;13(13):3158. https://doi.org/10.3390/cancers13133158.

    Article 
    CAS 

    Google Scholar
     

  • Ronellenfitsch U, Hohenberger P. Surgery for gastrointestinal stromal tumors: state of the art of laparoscopic resection and surgery for M1 tumors. Visc Med. 2018;34(5):367–74. https://doi.org/10.1159/000491799.

    Article 

    Google Scholar
     

  • Iordanou C, Theodoridis CA, Lykoudis PM, Dimitroulis D, Machairas N, Spartalis E, Kouki P, Pikoulis E, Nikiteas N. Current evidence on laparoscopic vs open resection for gastric stromal tumours. Oncol Lett. 2021;22(4):734. https://doi.org/10.3892/ol.2021.12995.

    Article 

    Google Scholar
     

  • Mechtersheimer G, Egerer G, Hensel M, Rieker RJ, Libicher M, Lehnert T, Penzel R. Gastrointestinal stromal tumours and their response to treatment with the tyrosine kinase inhibitor imatinib. Virchows Arch. 2004;444(2):108–18. https://doi.org/10.1007/s00428-003-0945-5.

    Article 
    CAS 

    Google Scholar
     

  • Steinert DM, McAuliffe JC, Trent JC. Imatinib mesylate in the treatment of gastrointestinal stromal tumour. Expert Opin Pharmacother. 2005;6(1):105–13. https://doi.org/10.1517/14656566.6.1.105.

    Article 
    CAS 

    Google Scholar
     

  • Rutkowski P, Gronchi A, Hohenberger P, Bonvalot S, Schöffski P, Bauer S, Fumagalli E, Nyckowski P, Nguyen BP, Kerst JM, Fiore M, Bylina E, Hoiczyk M, Cats A, Casali PG, Le Cesne A, Treckmann J, Stoeckle E, de Wilt JH, Sleijfer S, Tielen R, van der Graaf W, Verhoef C, van Coevorden F. Neoadjuvant imatinib in locally advanced gastrointestinal stromal tumors (GIST): the EORTC STBSG experience. Ann Surg Oncol. 2013;20(9):2937–43. https://doi.org/10.1245/s10434-013-3013-7.

    Article 

    Google Scholar
     

  • Wang J, Yin Y, Shen C, Yin X, Cai Z, Pu L, Fu W, Wang Y, Zhang B. Preoperative imatinib treatment in patients with locally advanced and metastatic/recurrent gastrointestinal stromal tumors: a single-center analysis. Medicine. 2020;99(9):e19275. https://doi.org/10.1097/MD.0000000000019275.

    Article 

    Google Scholar
     

  • Vassos N, Jakob J, Kähler G, Reichardt P, Marx A, Dimitrakopoulou-Strauss A, Rathmann N, Wardelmann E, Hohenberger P. Preservation of organ function in locally advanced non-metastatic gastrointestinal stromal tumors (GIST) of the stomach by neoadjuvant imatinib therapy. Cancers. 2021;13(4):586. https://doi.org/10.3390/cancers13040586.

    Article 
    CAS 

    Google Scholar
     

  • Wang D, Zhang Q, Blanke CD, Demetri GD, Heinrich MC, Watson JC, Hoffman JP, Okuno S, Kane JM, von Mehren M, Eisenberg BL. Phase II trial of neoadjuvant/adjuvant imatinib mesylate for advanced primary and metastatic/recurrent operable gastrointestinal stromal tumors: long-term follow-up results of Radiation Therapy Oncology Group 0132. Ann Surg Oncol. 2012;19(4):1074–80. https://doi.org/10.1245/s10434-011-2190-5.

    Article 
    CAS 

    Google Scholar
     

  • Wang SY, Wu CE, Lai CC, Chen JS, Tsai CY, Cheng CT, Yeh TS, Yeh CN. Prospective evaluation of neoadjuvant imatinib use in locally advanced gastrointestinal stromal tumors: emphasis on the optimal duration of neoadjuvant imatinib use, safety, and oncological outcome. Cancers. 2019;11(3):424. https://doi.org/10.3390/cancers11030424.

    Article 
    CAS 

    Google Scholar
     

  • Marqueen KE, Moshier E, Buckstein M, Ang C. Neoadjuvant therapy for gastrointestinal stromal tumors: a propensity score-weighted analysis. Int J Cancer. 2021;149(1):177–85. https://doi.org/10.1002/ijc.33536.

    Article 
    CAS 

    Google Scholar
     

  • Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Arch Pathol Lab Med. 2006;130(10):1466–78. https://doi.org/10.5858/2006-130-1466-GSTROM.

    Article 
    CAS 

    Google Scholar
     

  • Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–44. https://doi.org/10.1038/nature07205.

    Article 
    CAS 

    Google Scholar
     

  • Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–74. https://doi.org/10.1016/j.cell.2011.02.013.

    Article 
    CAS 

    Google Scholar
     

  • Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493-503. https://doi.org/10.1016/S1470-2045(14)70263-3.

    Article 

    Google Scholar
     

  • Roxburgh CS, McMillan DC. Role of systemic inflammatory response in predicting survival in patients with primary operable cancer. Fut Oncol. 2010;6(1):149–63. https://doi.org/10.2217/fon.09.136.

    Article 
    CAS 

    Google Scholar
     

  • Mantzorou M, Koutelidakis A, Theocharis S, Giaginis C. Clinical value of nutritional status in cancer: what is its impact and how it affects disease progression and prognosis? Nutr Cancer. 2017;69(8):1151–76. https://doi.org/10.1080/01635581.2017.1367947.

    Article 

    Google Scholar
     

  • Gupta D, Vashi PG, Lammersfeld CA, Braun DP. Role of nutritional status in predicting the length of stay in cancer: a systematic review of the epidemiological literature. Ann Nutr Metab. 2011;59(2–4):96–106. https://doi.org/10.1159/000332914.

    Article 
    CAS 

    Google Scholar
     

  • Hu B, Yang XR, Xu Y, Sun YF, Sun C, Guo W, Zhang X, Wang WM, Qiu SJ, Zhou J, Fan J. Systemic immune-inflammation index predicts prognosis of patients after curative resection for hepatocellular carcinoma. Clin Cancer Res. 2014;20(23):6212–22. https://doi.org/10.1158/1078-0432.CCR-14-0442.

    Article 
    CAS 

    Google Scholar
     

  • Hirahara N, Tajima Y, Matsubara T, Fujii Y, Kaji S, Kawabata Y, Hyakudomi R, Yamamoto T, Uchida Y, Taniura T. Systemic immune-inflammation index predicts overall survival in patients with gastric cancer: a propensity score-matched analysis. J Gastrointest Surg. 2021;25(5):1124–33. https://doi.org/10.1007/s11605-020-04710-7.

    Article 

    Google Scholar
     

  • Huang H, Liu Q, Zhu L, Zhang Y, Lu X, Wu Y, Liu L. Prognostic value of preoperative systemic immune-inflammation index in patients with cervical cancer. Sci Rep. 2019;9(1):3284. https://doi.org/10.1038/s41598-019-39150-0.

    Article 
    CAS 

    Google Scholar
     

  • Ding P, Guo H, Yang P, Sun C, Tian Y, Liu Y, Li Y, Zhao Q. Association between the nutritional risk and the survival rate in newly diagnosed GIST patients. Front Nutr. 2021;8:743475. https://doi.org/10.3389/fnut.2021.743475.

    Article 

    Google Scholar
     

  • Nakatani M, Migita K, Matsumoto S, Wakatsuki K, Ito M, Nakade H, Kunishige T, Kitano M, Kanehiro H. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy. Dis Esophagus. 2017;30(8):1–7. https://doi.org/10.1093/dote/dox020.

    Article 
    CAS 

    Google Scholar
     

  • Migita K, Matsumoto S, Wakatsuki K, Ito M, Kunishige T, Nakade H, Kitano M, Nakatani M, Kanehiro H. A decrease in the prognostic nutritional index is associated with a worse long-term outcome in gastric cancer patients undergoing neoadjuvant chemotherapy. Surg Today. 2017;47(8):1018–26. https://doi.org/10.1007/s00595-017-1469-y.

    Article 
    CAS 

    Google Scholar
     

  • Ding P, Guo H, Sun C, Yang P, Kim NH, Tian Y, Liu Y, Liu P, Li Y, Zhao Q. Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study. BMC Gastroenterol. 2022;22(1):121. https://doi.org/10.1186/s12876-022-02199-9.

    Article 
    CAS 

    Google Scholar
     

  • Ding P, Yang P, Sun C, Tian Y, Guo H, Liu Y, Li Y, Zhao Q. Predictive effect of systemic immune-inflammation index combined with prognostic nutrition index score on efficacy and prognosis of neoadjuvant intraperitoneal and systemic paclitaxel combined with apatinib conversion therapy in gastric cancer patients with positive peritoneal lavage cytology: a prospective study. Front Oncol. 2022;11:791912. https://doi.org/10.3389/fonc.2021.791912.

    Article 

    Google Scholar
     

  • Yilmaz A, Mirili C, Bilici M, Tekin SB. A novel predictor in patients with gastrointestinal stromal tumors: systemic immune-inflammation index (SII). J BUON. 2019;24(5):2127–35.


    Google Scholar
     

  • Sun J, Mei Y, Zhu Q, Shou C, Tjhoi WEH, Yang W, Yu H, Zhang Q, Liu X, Yu J. Relationship of prognostic nutritional index with prognosis of gastrointestinal stromal tumors. J Cancer. 2019;10(12):2679–86. https://doi.org/10.7150/jca.32299.

    Article 
    CAS 

    Google Scholar
     

  • von Mehren M, Kane JM, Bui MM, Choy E, Connelly M, Dry S, et al. NCCN Guidelines Insights: soft tissue sarcoma, version 1.2021. J Natl Compr Canc Netw. 2020;18(12):1604–12. https://doi.org/10.6004/jnccn.2020.0058.

    Article 
    CAS 

    Google Scholar
     

  • Shen L, Cao F, Qin SK, Ye YJ, Li J, Wang J, et al. Chinese consensus on the diagnosis and treatment of gastrointestinal mesenchymal tumors (2017 edition). Electr J Compr Cancer Therapy. 2018;4(01):31–43.


    Google Scholar
     

  • Choi H. Response evaluation of gastrointestinal stromal tumors. Oncologist. 2008;13(Suppl 2):4–7. https://doi.org/10.1634/theoncologist.13-S2-4.

    Article 

    Google Scholar
     

  • Li J, Ye Y, Wang J, Zhang B, Qin S, Shi Y, He Y, Liang X, Liu X, Zhou Y, Wu X, Zhang X, Wang M, Gao Z, Lin T, Cao H, Shen L. Chinese Society Of Clinical Oncology Csco Expert Committee On Gastrointestinal Stromal Tumor: Chinese consensus guidelines for diagnosis and management of gastrointestinal stromal tumor. Chin J Cancer Res. 2017;29(4):281–93. https://doi.org/10.21147/j.issn.1000-9604.2017.04.01.

    Article 

    Google Scholar
     

  • Al-Share B, Alloghbi A, Al Hallak MN, Uddin H, Azmi A, Mohammad RM, Kim SH, Shields AF, Philip PA. Gastrointestinal stromal tumor: a review of current and emerging therapies. Cancer Metastasis Rev. 2021;40(2):625–41. https://doi.org/10.1007/s10555-021-09961-7.

    Article 
    CAS 

    Google Scholar
     

  • Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759–71. https://doi.org/10.1038/nrc3611.

    Article 
    CAS 

    Google Scholar
     

  • Choi Y, Kim JW, Nam KH, Han SH, Kim JW, Ahn SH, Park DJ, Lee KW, Lee HS, Kim HH. Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer. Gastric Cancer. 2017;20(4):602–11. https://doi.org/10.1007/s10120-016-0642-0.

    Article 
    CAS 

    Google Scholar
     

  • Ding P, Guo H, Sun C, Yang P, Tian Y, Liu Y, Zhang Z, Wang D, Zhao X, Tan B, Liu Y, Li Y, Zhao Q. Relationship between nutritional status and clinical outcome in patients with gastrointestinal stromal tumor after surgical resection. Front Nutr. 2022;9:818246. https://doi.org/10.3389/fnut.2022.818246.

    Article 
    CAS 

    Google Scholar
     

  • Yamanaka T, Matsumoto S, Teramukai S, Ishiwata R, Nagai Y, Fukushima M. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007;73(3–4):215–20. https://doi.org/10.1159/000127412.

    Article 

    Google Scholar
     

  • Suarez-Carmona M, Lesage J, Cataldo D, Gilles C. EMT and inflammation: inseparable actors of cancer progression. Mol Oncol. 2017;11(7):805–23. https://doi.org/10.1002/1878-0261.12095.

    Article 

    Google Scholar
     

  • Zhou C, Liu J, Tang Y, Liang X. Inflammation linking EMT and cancer stem cells. Oral Oncol. 2012;48(11):1068–75. https://doi.org/10.1016/j.oraloncology.2012.06.005.

    Article 
    CAS 

    Google Scholar
     

  • Yuce E, Alandag C, Cakir E, Fidan E. Prognostic factors in gastrointestinal stromal tumors (GIST): could prognostic nutritional index (PNI) be a new prognostic factor? J Coll Physicians Surg Pak. 2022;32(1):81–5. https://doi.org/10.29271/jcpsp.2022.01.81.

    Article 

    Google Scholar
     

  • Lu Z, Li R, Cao X, Liu C, Sun Z, Shi X, Shao W, Zheng Y, Song J. Assessment of systemic inflammation and nutritional indicators in predicting recurrence-free survival after surgical resection of gastrointestinal stromal tumors. Front Oncol. 2021;11:710191. https://doi.org/10.3389/fonc.2021.710191.

    Article 

    Google Scholar
     

  • Shau HY, Golub SH. Inhibition of lymphokine-activated killer- and natural killer-mediated cytotoxicities by neutrophils. J Immunol. 1989;143(3):1066–72.

    Article 
    CAS 

    Google Scholar
     

  • Gong Y, Koh DR. Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model. Cell Tissue Res. 2010;339(2):437–48. https://doi.org/10.1007/s00441-009-0908-5.

    Article 

    Google Scholar
     

  • Verheul HM, Jorna AS, Hoekman K, Broxterman HJ, Gebbink MF, Pinedo HM. Vascular endothelial growth factor-stimulated endothelial cells promote adhesion and activation of platelets. Blood. 2000;96(13):4216–21.

    Article 
    CAS 

    Google Scholar
     

  • Whiteside TL. Immune modulation of T-cell and NK (natural killer) cell activities by TEXs (tumour-derived exosomes). Biochem Soc Trans. 2013;41(1):245–51. https://doi.org/10.1042/BST20120265.

    Article 
    CAS 

    Google Scholar
     

  • Feng XY, Wen XZ, Tan XJ, Hou JH, Ding Y, Wang KF, Dong J, Zhou ZW, Chen YB, Zhang XS. Ectopic expression of B and T lymphocyte attenuator in gastric cancer: a potential independent prognostic factor in patients with gastric cancer. Mol Med Rep. 2015;11(1):658–64. https://doi.org/10.3892/mmr.2014.2699.

    Article 
    CAS 

    Google Scholar
     



  • Source link

    Back to top button